1. Li, Linrong, Li, Lin, Sun, Qiang. 2022. High expression of cuproptosis-related SLC31A1 gene in relation to unfavorable outcome and deregulated immune cell infiltration in breast cancer: an analysis based on public databases. In BMC bioinformatics, 23, 350. doi:10.1186/s12859-022-04894-6. https://pubmed.ncbi.nlm.nih.gov/35996075/
2. Qi, Yue, Yao, Qingqing, Li, Xuanyan, Zhang, Wenwen, Qu, Pengpeng. 2023. Cuproptosis-related gene SLC31A1: prognosis values and potential biological functions in cancer. In Scientific reports, 13, 17790. doi:10.1038/s41598-023-44681-8. https://pubmed.ncbi.nlm.nih.gov/37853210/
3. Mi, Jiaoping, Luo, Juncong, Zeng, Huanwen, Zhang, Ning, Xiao, Mei. 2023. Elucidating cuproptosis-related gene SLC31A1 diagnostic and prognostic values in cancer. In American journal of translational research, 15, 6026-6041. doi:. https://pubmed.ncbi.nlm.nih.gov/37969191/
4. Wang, Jun, Li, Shenglun, Guo, Yuduo, Yang, Jingjing, Zhang, Hongwei. 2023. Cuproptosis-related gene SLC31A1 expression correlates with the prognosis and tumor immune microenvironment in glioma. In Functional & integrative genomics, 23, 279. doi:10.1007/s10142-023-01210-0. https://pubmed.ncbi.nlm.nih.gov/37610668/
5. Li, Xiao, Ma, Zhaosheng, Mei, Linhang. 2022. Cuproptosis-related gene SLC31A1 is a potential predictor for diagnosis, prognosis and therapeutic response of breast cancer. In American journal of cancer research, 12, 3561-3580. doi:. https://pubmed.ncbi.nlm.nih.gov/36119835/